| Sandy G Moody, LCSW | |
|
695 N 1170 East Cir, American Fork, UT 84003-3547 | |
| (801) 231-7724 | |
| Not Available |
| Full Name | Sandy G Moody |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 18 Years |
| Location | 695 N 1170 East Cir, American Fork, Utah |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346514726 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Secondary |
| 101YM0800X | Counselor - Mental Health | 6236523-3501 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sandy G Moody, LCSW 695 N 1170 East Cir, American Fork, UT 84003-3547 Ph: () - | Sandy G Moody, LCSW 695 N 1170 East Cir, American Fork, UT 84003-3547 Ph: (801) 231-7724 |
News Archive
Using induced pluripotent stem cells (iPSCs) and deleting a key gene, researchers at University of California San Diego School of Medicine have created natural killer cells -; a type of immune cell -; with measurably stronger activity against a form of leukemia, both in vivo and in vitro.
In the midst of the raging coronavirus pandemic, we're faced with agonizing decisions about whether to forgo treasured holiday rituals.
In the first study to analyze the impact of genetic factors on multiple stages of tobacco use in both men and women, a team of researchers from Virginia Commonwealth University has found some of the strongest evidence yet for the role of genetic factors in smoking.
As part of the federal government's ongoing effort to improve the lives of organ transplant recipients and patients awaiting organ transplants, the Health Resources and Services Administration (HRSA) has awarded researchers at the Minneapolis Medical Research Foundation (MMRF) a multimillion-dollar contract to maintain and analyze data on solid-organ transplantation in the United States.
Exelixis, Inc. today announced that the U.S. Food & Drug Administration (FDA) has granted orphan drug designation to XL184 for treatment of follicular, medullary, and anaplastic thyroid carcinoma, and metastatic or locally advanced papillary thyroid cancer. A pivotal phase 3 trial of XL184 is ongoing in patients with medullary thyroid cancer (MTC) and the company expects to release top-line phase 3 results in the first-half of 2011 and potentially file a New Drug Application (NDA) for the compound in the second-half of 2011.
› Verified 2 days ago
Jennifer Roach, MA, LCMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 342 S 850 W Apt 306, American Fork, UT 84003 Phone: 206-427-7754 Fax: 425-258-5275 | |
Chelsey Wood, Counselor Medicare: Not Enrolled in Medicare Practice Location: 433 S 500 E, American Fork, UT 84003 Phone: 801-216-8000 | |
Katie Gooch, LMFT Counselor Medicare: Not Enrolled in Medicare Practice Location: 384 E 60 S, American Fork, UT 84003 Phone: 801-901-0279 | |
Ms. Donna F. Kendall, LPC, NCC Counselor Medicare: Not Enrolled in Medicare Practice Location: Lds Family Services, 500 South State, American Fork, UT 84003 Phone: 801-226-8000 | |
Kimberly Schneider, Counselor Medicare: Not Enrolled in Medicare Practice Location: 71 N 490 W, American Fork, UT 84003 Phone: 801-763-7775 | |
Katie Borski, Counselor Medicare: Not Enrolled in Medicare Practice Location: 71 N 490 W, American Fork, UT 84003 Phone: 801-763-7775 | |
Mr. Wayne Sears, CMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 802 E Bamberger Dr Ste D, American Fork, UT 84003 Phone: 801-633-7677 |